Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Balasundaram, S.
Right arrow Articles by Duran, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Balasundaram, S.
Right arrow Articles by Duran, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A safe technique for cardiopulmonary bypass in sickle cell disease

S. Balasundaram

Department of Cardiovascular Diseases, King Faisal Specialist Hospital, Riyadh

M. Kassay

Department of Cardiovascular Diseases, King Faisal Specialist Hospital, Riyadh

Cmg Duran

Department of Cardiovascular Diseases, King Faisal Specialist Hospital, Riyadh

The use of exchange transfusion at the beginning of cardiopulmonary bypass (CPB) in five cases of sickle cell anaemia is described. The patient's circulating blood volume was drained into a bag through side tubing attached to the venous drainage line. Cardiopulmonary bypass was started with a prime consisting of donor packed cells, fresh frozen plasma, 25% albumin, lactated Ringer's solution, sodium bicarbonate and heparin. Moderate hypothermia, aortic crossclamping, topical hypothermia and cold crystalloid cardioplegia were used in all cases. The drained blood was spun down and the serum containing normal platelets and clotting factors was retransfused to the patient at the end of the operation. All five patients survived the procedure without complications and no homologous blood transfusion was required.

Perfusion, Vol. 5, No. 4, 291-295 (1990)
DOI: 10.1177/026765919000500408


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?